Abstract
Coronavirus disease 2019 (COVID19) is a respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originating in Wuhan, China in 2019. The disease is notably severe in elderly and those with underlying chronic conditions. A molecular mechanism that explains why the elderly are vulnerable and why children are resistant is largely unknown. Here we show loading cells with cholesterol from blood serum using the cholesterol transport protein apolipoprotein E (apoE) enhances the entry of pseudotyped SARS-CoV-2 and the infectivity of the virion. Super resolution imaging of the SARS-CoV-2 entry point with high cholesterol shows almost twice the total number of endocytic entry points. Cholesterol concomitantly traffics angiotensinogen converting enzyme (ACE2) to the endocytic entry site where SARS-CoV-2 presumably docks to efficiently exploit entry into the cell. Furthermore, in cells producing virus, cholesterol optimally positions furin for priming SARS-CoV-2, producing a more infectious virion with improved binding to the ACE2 receptor. In vivo, age and high fat diet induces cholesterol loading by up to 40% and trafficking of ACE2 to endocytic entry sites in lung tissue from mice. We propose a component of COVID19 severity based on tissue cholesterol level and the sensitivity of ACE2 and furin to cholesterol. Molecules that reduce cholesterol or disrupt ACE2 localization with viral entry points or furin localization in the producer cells, may reduce the severity of COVID19 in obese patients.
INTRODUCTION
In early 2020, COVID19 spread rapidly throughout the developed world leading to extensive death and an ongoing pandemic. The lethality of SARS-CoV-2 is notably selective for elderly1,2 and those with chronic disease such as hypertension, diabetes, Alzheimer’s, cardiovascular disease, and smoking3–5 although in the case of smoking not without controvery6. Interestingly, almost all children present with very minor symptoms, while elderly and those with underlying conditions experience very severe life-threatening symptoms leading to much higher death rates7. This disparity was also observed with SARS-CoV, a closely related virus which failed to kill any children under the age of 12, despite being much more lethal than SARS-CoV-2 in adults8. Understanding why young people are resistant in this class of viruses could help both healthy and chronically ill adults to avoid severe symptoms of COVID19.
At least two factors affect SARS-CoV-2 infectivity, 1) the opportunity of the virus to bind to the cell surface and 2) the ability of the virus to enter the cell. SARS-CoV-2 attaches to the cell surface by binding to a receptor, angiotensinogen converting enzyme 2 (ACE2)9,10. Once bound, the virus can enter through an apparent cell surface mechanism10,11 or through clathrin-mediated endocytosis12, a cholesterol dependent mechanism that involves monosialotetrahexosylganglioside1 (GM1) containing lipid clusters (also known as lipid rafts, see Supplemental Figure S1A)13–15. Regardless of the pathway, the virus must be primed by proteases16. In SARS-CoV-2 there is an efficient furin cleavage site between the S1 and S2 segments that is not found in SARS-CoV17,18.
Cholesterol is an insoluble eukaryotic lipid found in membranes throughout the human body, most notably in the plasma membrane19. It appears to accumulate in tissue with age20–22. Furthermore, chronic inflammation causes cholesterol loading into macrophage rich tissue23. Pneumocytes and macrophages in the lung uptake and efflux cholesterol and this process is associated with lung disease24 and lung function25,26. Recently cholesterol has been shown to be a key factors in SARS-CoV-2 infections27–30, but a molecular mechanism for cholesterols effects is unclear. For further discussion on cholesterol in peripheral tissue see Figure S1B.
We recently showed a cholesterol-dependent mechanism for anesthetics that regulates the translocation of membrane proteins between GM1 and PIP2 lipid clusters31,32. Previous experiments showed ACE2 can associate with detergent resistant membranes (DRMs)15,33 which are similar in composition to GM1 clusters. Here we show ACE2 protein levels are low under native conditions in human lung and levels are low in most cells types including lung. Furthermore, ACE2 translocates between GM1 and PIP2 clusters and increased cholesterol contributes to infectivity and ACE2 localization to GM1 lipids in mouse lung providing a molecular mechanism for cholesterol to regulate SARS-CoV-2 entry.
RESULTS
Measurements of cholesterol and ACE2 protein levels in human lung tissue.
The level of ACE2 expression and cholesterol have been cited as a reason for SARS-CoV-2 infectivity, but little is known about the relative levels of ACE2 protein and cholesterol in cells types that are easily infected vs not easily infected with the virus. To better compare cells of known infectivity with those of low infectivity we examined cholesterol levels in VeroE6 cells and compared them to HEK293T cells. Vero E6 cells are a kidney cell line that are highly infected with SARS-CoV-2 virus34. We also compared cholesterol of smoker’s to cultured carcinoma lung cells A549 and H1793. Human lung cells are susceptible to infection while cultures lungs cells are relatively resistant. We found that cultured cells have between 50–70% less free cholesterol (FC) compared to lung tissue from smokers (Figure 1A).
To test the potential role of increased ACE2 expression in SARS-CoV-2 infectivity, we compared ACE2 protein levels in lung tissue of smokers (epithelial airway) with the various cultured cell types using an ELISA assay for ACE2 protein. We found the highest endogenous levels of ACE2 protein in HEK293T and the lowest in the lung of smokers (Figure 1B) although none were significantly different and all of them were relatively low levels. This is consistent with low levels of endogenous ACE2 in HEK293T cells observed by westernblot35, but opposite to those who have used RNA as an indirect surrogate for ACE2 protein expression36.
To confirm the presence of endogenously expressed ACE2 in the membrane of WT HEK293T cells, we performed an ACE2 activity assay using a fluorescent substrate cleavage assay. The ACE2 specific inhibitor DX600 decreased fluorescence 70% compared to control (Figure 2E), confirming ACE2 enzyme is present and active in HEK293T cells.
Over expression of ACE2 renders HEK293T cells highly susceptible to infection. Given the similar level of ACE2 protein measured in WT HEK293T compared to other endogenous cell types, we investigated the relative effect of ACE2 overexpression in HEK293T cells. We observed ~20 times more ACE2 protein in over expressing cells compared to endogenous systems (Figure 1B) and ~100 times higher SARS-PV infectivity (Figure 1C) compared to WT HEK293T. The non-physiological condition of over-expression combined with the fact that ACE2 levels were the same in VeroE6 and HEK293T cells despite their dramatic difference in infectivity led us to consider the cholesterol-based mechanisms of infectivity.
At a whole membrane level, one function of cholesterol is to cluster membrane proteins37 including immune proteins in order to facilitate an immune response38. Clustering can also increase viral entry39,40 suggesting cholesterol induced clustering could be a factor influencing SARS-CoV-2 entry. To test a potential role for cholesterol we compared highly infectable VeroE6 cells with poorly infected HEK293T cells.
We found that VeroE6 cells had the highest amount of FC, ~20% more than HEK293T (Figure 1B, D). Interestingly, total cholesterol (FC + cholesteryl esters (CE)) was roughly the same (Figure 1E). FC is typically in the plasma membrane whereas esterified cholesterol is more prominent in internal stores27–29. We reasoned that cholesterol should produce a change in GM1 lipid clustering in Vero E6 cells v.s. HEK293T cells. To test GM1 clustering, we fluorescently labeled GM1 lipids with cholera toxin B and imaged the average apparent cluster size using direct stochastical optical reconstruction microscopy (dSTORM). dSTORM and other super-resolution techniques are capable of visualizing nanoscale arrangements (i.e. sub-100 nm diameter lipid domain structures) in intact cellular membranes41–43. We found Vero E6 have extremely large GM1 clusters, on average 200 nm in diameter, almost twice that of HEK293T cells (Figure 1F). These results suggest that although the total cholesterol level in HEK293T and Vero E6 are the same, the distribution of cholesterol in different cellular compartments are different. Compared with HEK293T, VeroE6 has more cholesterol in the plasma membrane, contributing to GM1 lipid clusters with higher integrity.
Cholesterol dependent SARS-CoV-2 pseudovirus entry.
To directly test the cholesterol dependence of SARS-CoV-2 entry we infected HEK293T cells with retrovirus pseudotyped with the SARS-CoV-2 S protein (SARS2-PV), a segment of the S protein which binds to the ACE2 receptor and recapitulates viral entry44,45. Viral particles were prepared fresh to maximize HEK293T infection. Cholesterol was loaded with 4 μg/mL apolipoprotein E (apoE). ApoE is a cholesterol carrier protein linked to Alzheimer’s and the severity of COVID1946. In tissue, apoE binds to low-density lipoprotein (LDL) receptor and facilitates loading and unloading of cholesterol into cells (Figure 2A). When apoE is in excess in low cholesterol conditions, it facilitates efflux of cholesterol from the cell47 (Supplemental Figure S1B). To provide a source of cholesterol to the apoE, we added 10% fetal bovine serum (FBS), a common source of cholesterol ~310 μg/mL. Importantly, apoE is not present in FBS48 allowing us to carefully control cholesterol loading. Cells were treated acutely (1 hr.) with apoE. We adapted the technique from our studies of cholesterol loading in the central nervous system49.
We found cholesterol loading (apoE + serum) significantly increased SARS2-PV entry in HEK293T cells. Figure 2B shows viral entry increased 50% compared to control (serum only). Cholesterol efflux (apoE- serum) had the opposite effect; viral entry decreased almost 50% (Figure 2B). Similar effect was also observed in Vero E6 cells (Figure 2C). Methyl-beta-cyclodextrin (MβCD), a chemical known to extract cholesterol from the membrane of cells, inhibited more than 90% of SARS2-PV entry (Figure 2D). To avoid any potential effect of cholesterol directly on the virion, the cells were pretreated for all cholesterol conditions (one hour), washed and then exposed to the virion, i.e., the virion did not experience any cholesterol treatment, only the cells.
VSV-G is an genetically unrelated virus that enter through a cholesterol dependent endocytic pathway. We found infection of cells with a pseudotyped VSV-G had less sensitivity to cholesterol compared to SARS2-PV with identical treatment, although a similar trend was visible as expected for a cholesterol dependent pathway (Supplemental Figure S2A). Likewise, cholesterol modulation with MβCD had a much less effect on VSV-G viral entry compared to SARS-CoV-2 (Supplemental Figure S2B) confirming that SARS-CoV-2 is particularly sensitive to cholesterol.
We also tested the effect of cholesterol on ACE2 activity. Using a fluorescent ACE2 substrate we showed activity increased ~40% with apoE (cholesterol loaded) compared to no apoE (cholesterol depleted), suggesting cholesterol regulates ACE2’s endogenous enzymatic activity is in HEK293T cells.
Cholesterol dependent trafficking of the ACE2 receptor to GM1 endocytic entry point.
In biological membranes we have shown select cluster associated proteins easily move between clusters of GM1 lipids and clusters of phosphatidylinositol 4,5-bisphate (PIP2) lipids with changing cellular cholesterol levels (e.g. phospholipase D2), while other proteins remain clustered with GM1 lipids (e.g. beta and gamma secretase)31,32,49. Given the sensitivity of SARS2-PV to cholesterol, we hypothesized that the ACE2 receptor may likewise easily shift between an endocytic pathway and a cell surface mechanism based on cholesterol levels in the plasma membrane.
To determine the amount of ACE2 positioned in a GM1 endocytic pathway, we co-labeled ACE2 and GM1 clusters in HEK293T cells with Cy3b labeled ACE2 antibody and Alexa Fluor 647 conjugated fluorescent CTxB (a GM1 specific toxin), treated cells with apoE/serum, and imaged with two color dSTORM.
Figure 3A shows representative dSTORM images of ACE2 and GM1 clusters from apoE treated cells with and without serum exposure (i.e., cells loaded or not loaded with cholesterol, respectively). The association of ACE2 with GM1 clusters was measured by pairwise correlation. Pairwise correlation measures the probability that two molecules are next to each other. For our experiments we compared the pair correlation at the closest radii (5 nm) as a percentage of control cells without apoE.
We found pairwise correlation of ACE2 with GM1 clustered increased more than 3-fold in cholesterol loaded cells (Figure 3B). We loaded cholesterol using 4 μg/mL apoE and 10% serum, the same as our viral entry assay. The increased correlation was not due to a change in ACE2 concentration on the cell surface (Supplemental Figure S3A–B). As a positive control, and to confirm the effect depends on cholesterol and not another component of the serum or apoE regulation, we treated the cells with MβCD. In agreement with our viral entry assay, MβCD reduced ACE2 localization with GM1 lipids by ~70% (Supplemental Figure S3C).
We then co-labeled ACE2 with an antibody that binds (PIP2) lipids. PIP2 is a polyunsaturated signaling lipid that forms cholesterol independent domains50 in the disordered regions away from GM1 clusters32,50–52 (See supplemental Figure S1A). As expected, PIP2 pair correlation was opposite of GM1, loading cells with cholesterol decreased the association of PIP2 and ACE2 (Figure 3B). These data suggest that cholesterol moves ACE2 from PIP2 clusters to GM1 clusters (Figure 3C). Can you have gradients of cholesterol within a plasma membrane – current model of high or low cholesterol seems overly simplistic
We next investigated the effect cholesterol has on the number of GM1 clusters in the plasma membrane—presumably an estimate of the number of GM1 labeled endocytic entry points for ACE2. Using cluster analysis, we found cells loaded with cholesterol (+apoE) increased in both the number and apparent diameter of GM1 labeled clusters compared to serum only (not loaded control) (Figure 3D–E). Cholesterol depletion by MβCD also robustly decrease the apparent cluster size (Figure S3D). These decreases caused GM1 clusters to separate from each other measured by Ripley’s H function. (Figure S3E). The cells were fixed prior to labeling to reduce potential artifacts in their diameter size due to CTxB clustering53 (see methods).
Cholesterol loading into lung tissue.
For cholesterol to have an effect in vivo, the cholesterol must be loaded into the cells where the ACE2 expressing cells are located during an infection. To determine whether there is an age-dependent effect on cellular cholesterol we measured cholesterol levels in young (8-week-old) and aged (28-week-old) lungs from C57BL/6J mice. Lungs were fixed, removed, and 2.5 mg of lung tissue assayed. We found cholesterol in the lung of older adults was elevated (~45%) compared to young mice (Figure 4A). The increase was significant with a P value less than 0.01.
Next we investigated cholesterol levels in lung tissue in aged (28 week) diabetic animals. We increased cholesterol by diet induced obesity (DIO), a well-established mouse model for type II diabetes in of C57B/6J mice54. We noted the weight of the obese lung was increased compared to healthy lung (Supplemental Figure S2C), most likely due to increased fluid permeability in the diabetic mouse. To control for potential excess water in the diabetic mice, we normalized the amount of cholesterol to total protein in the tissue homogenate. Cholesterol normalized per μg of protein was significantly elevated in DIO mice compared to both 8 week and 28-week-old healthy mice (40% and 22% respectively). The increase in lung cholesterol was consistent with the uptake of cholesterol into into cultured cells and suggests an age and obesity induced sensitivity to viral infection exists in vivo.
To further confirm a cholesterol dependent effect, we tested ACE2 localization to GM1 clusters in whole lung slices from obese mice. The percent pair correlation for 28wo was more than an order of magnitude higher in lungs from obese mice albeit highly variable (N=10). Nonetheless the trend was consistently higher than either young or control untreated mice (Figure 4C). Labeling in lung was sparser than in our tissue culture (Figure 4E), which likely contributing to the variability. Figure 4F shows an ACE2 based model for age and disease related SARS2 infectivity. In aged obese mice, ACE2 shifts to the GM1 clusters and facilitates viral entry.
Cholesterol dependent furin localization.
During the preparation of pseudovirus, this site appears to be mostly cut in the producing cells10,18. For the virus to interact with a protease it must be in proximity (i.e., the same lipid compartment).
Palmitoylation is a post translation modification that attaches a 16 carbon saturated lipid to many proteins and traffics them to GM1 clusters37. Palmitoylation of the cysteine-rich endodomain of the SARS-CoV spike glycoprotein is important for spike-mediated cell fusion and viral entry55,56. Little is known about palmitoylation of SARS-CoV-2. We aligned SARS-CoV and SARS-CoV-2 and found that all 9 putative palmitoylation sites in SARS-CoV are conserved in SARS-CoV-2 (Figure S4A). A single significant mutation (alanine to cysteine) introduces an additional putative palmitoylation site in SARS-CoV-2, which suggest SARS-CoV-2 remains under evolutionary pressure for palmitate driven viral infectivity.
In a virus producing cell, SARS-CoV-2 palmitoylation is positioned on the intracellular leaflet suitable for targeting the nascent spike protein to GM1 clusters. To test a potential role of cholesterol in facilitating SARS-CoV-2 priming, we loaded producing cells (HEK293T) with cholesterol and imaged furin trafficking in and out of GM1 clusters. Cholesterol (apoE + serum) increased furin’s pair correlation with GM1 clusters, a location that likely favors hydrolysis of the spike protein at the S1/S2 site and facilitates priming of the virus. Unloading cholesterol from the cells (apoE - serum or MβCD) dramatically decreased the percent of furin associated with GM1 clusters (Figure 5A and Supplemental Figure S4B).
A lack of furin priming has been shown to decrease viral entry18. If furin priming is decreased with low cholesterol, we expect virion from low cholesterol to also produce less infectious virion. We expressed SARS2-PV in low cholesterol cells pretreated with 4 μg/ml apoE. Figure 5B shows depletion of cholesterol in producer cells yields a much weaker virion. Viral entry into normal control target cells decreased by 50%, suggesting low cholesterol likely decreases priming of the virions.
To confirm reduced cholesterol is similar to inhibited furin in our assay, we produced SARS2-PV in the presence of a furin specific inhibitor and tested viral entry. Entry was reduced ~ 50% for unprimed virus, consistent with previous results and our hypothesis (Figure 5C). Adding the inhibitor in the target cell, after the virus is already primed, had no effect (Figure 5C and Supplemental Figure S4C), suggesting furin does not cut an unprimed virion in the target cell.
Figure 5D shows a proposed model for enhanced viral entry in old compared to young due to increased S1/S2 priming in virus producing cells. In young individuals the furin is trafficked outside of GM1 clusters resulting in decreased access of the spike protein to furin. In high cholesterol, furin translocates into GM1 clusters near virus. Low cholesterol in the virion envelope may also contribute to the low infectivity and or recycling of furin into the Golgi (not shown).
Cholesterol dependent SARS-CoV-2 receptor binding
The effectiveness of viral entry in the disordered region could also result from reduced binding to the ACE2 in the disordered region. To test SARS-CoV-2 binding, we applied the SARS-CoV-2 receptor binding domain (RBD) to HEK293T cells with and without MβCD. MβCD treatment reduced the binding of the RBD (Supplemental Figure S4D). This difference in binding was not seen in SARS-CoV15, suggesting the virus may have evolved to bind tighter to GM1 localized ACE2. However, the effect was modest and suggests viral entry rather than binding is likely more affected by cholesterol.
DISCUSSION
Taken together our findings show the level of cellular cholesterol is a core contributor to SARS-CoV-2 viral entry. A proposed model for age and disease dependent infection of SARS-CoV-2 is shown in Figure 4F. When cholesterol is low (similar to children) there are fewer GM1 entry points, they are smaller, and ACE2 is associated primarily with PIP2 clusters. With age, average cellular cholesterol levels in the lung increases and the number and size of GM1 entry points increases. In chronically ill patients, cellular cholesterol levels increase dramatically and ACE2 receptor shifts to the GM1 entry a location that is presumably more efficient when tissue cholesterol is high (adults + chronic inflammation). The model is supported by data from smokers, age dependent loading of cholesterol into lung tissue of mice (Figure 4A–B), increased size of GM1 clusters in cholesterol and the simultaneous translocation of ACE2 from PIP2 domains to GM1 clusters (Figure 3C).
SARS viruses are thought to have two entry mechanisms, surface and endocytic. The nanoscopic trafficking of ACE2 from PIP2 to GM1 clusters suggests the mechanism of viral entry is likely different in young healthy animals compared to chronically inflamed and aged animals. GM1 clusters are clearly part of the endocytic pathway and pertinent during high cholesterol. Whether PIP2 is part of the surface entry mechanism is unknown and would likely be most pertinent to young healthy animals. Over expression of the protease TMPRSS2 greatly facilitates SARS-CoV-2 viral entry34. Under normal TMPRESS2 expression, PIP2 may cluster ACE2 away from TMPRSS2. However, the protease does not seem to be necessary, at least not with high cholesterol, as VeroE6 have no detectible TMPRSS2 mRNA and they are easily infected with SARS-CoV-234.
Interestingly, blood cholesterol was found to be lower in the most severe cases of COVID 19 while the cholesterol in the monocytes from the same individuals was elevated57. Since we measured free cholesterol in the tissue, we expect a result similar to the blood monocytes, not serum. The high cholesterol in monocytes is consistent with cholesterol loading into tissue during chronic inflammation and suggests blood cholesterol many not always correlate with tissue cholesterol.
ACE2 association with PIP2 lipid domains is very similar to our previous finding with phospholipase D2. PIP2 opposes the function of GM1 clusters by trafficking the proteins away32,58. These results suggest that cholesterol is likely in balance with PIP2 in the membrane to regulate the trafficking of an ACE2 in or out of the GM1 cluster and this may change with age and disease.
According to our model, drugs that disrupt GM1 clusters, or drugs that increase cholesterol efflux, are likely to help critically ill COVID19 patients. We and others have shown that polyunsaturated fatty acids, anesthetics, and mechanical force oppose cholesterol signaling through GM1 clusters31,32,58,59. Drugs that inhibit cholesterol synthesis, including statins28, could also be helpful, especially if taken over time to avoid early infectivity.
METHODS
Cell culture
Human embryonic kidney 293T (HEK293T) cells and HEK293T cells overexpressing human ACE2 (hACE2) were grown in Dulbecco’s Modified Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin.
HEK293T cells overexpressing hACE2 were generously provided by Dr. Michael Farzan (Department of Immunology and Microbiology, Scripps Research). Cells were generated by transduction with murine leukemia virus (MLV) pseudotyped with the vesicular stomatitis virus G protein and expressing myc-hACE2-c9, as previously described56. Briefly, HEK293T cells were co-transfected by PEI with three plasmids, pMLV-gag-pol, pCAGGS-VSV-G and pQCXIP-myc-hACE2-c9 at a ratio of 3:2:1, and medium was refreshed after overnight incubation of transfection mix. The supernatant with produced virus was harvested 72-hours post transfection and clarified by passing through 0.45μm filter. 293T-hACE2 cells were selected and maintained with medium containing puromycin (Sigma). hACE2 expression was confirmed by SARS2-PV entry assays and by immunofluorescence staining using mouse monoclonal antibody recognizing c-Myc.
Production of SARS-CoV-2 pseudoviruses
Retroviruses pseudotyped with the SARS-CoV-2 S proteins (SARS2-PV) was produced as previously described22,23 with modest modifications as described. HEK293T cells were transfected by X-tremeGENE™ 9 DNA Transfection Reagent (Millipore Sigma, #6365787001) at a ratio of 5:5:1 with a plasmid encoding murine leukemia virus (MLV) gag/pol proteins, a retroviral vector pQCXIX expressing firefly luciferase, and a plasmid expressing the spike protein of SARS-CoV-2 (GenBank YP_009724390) or a control plasmid (VSV-G). All the viral plasmids were provided by Dr. Michael Farzan. Cell culture supernatant containing pseudoviruses was harvested at 72 hours post transfection. For furin inhibitor or apoE treatment, cells were incubated with 25 μM hexa-D-arginine amide (Furin Inhibitor II, Sigma-Aldrich, # SCP0148) or 4 μg/mL apoE (BioVision, #4696–500) respectively, over the process of viral production starting 6 hours after transfection. Virus were then buffer exchanged with Amicon Ultra-4 Centrifugal Unit (Millipore Sigma, #UFC800396) to get rid of furin inhibitor in the media.
Viral entry assay
HEK293T cells were cultured in 96-well flat culture plates with transparent-bottom (Corning™ Costar™, #3585) pre-coated with poly-D-lysine. Cells were incubated with media containing 4 μg/mL apoE with or without FBS supplementation overnight before viral exposure. For MβCD treatment, cells were incubated with 100 μM MβCD for 30 min prior to virus infection. For furin inhibitor treatment, cells were incubated with 25 μM hexa-D-arginine amide for 1 hour prior to and during the whole process of virus infection.
SARS-CoV-2 pseudoviruses were applied to the cells and allowed to infect at 37 °C for 24 hours. After viral infection, efficiency of viral entry was determined through a firefly luciferase assay. Specifically, cells were washed with PBS once and 16 μL Cell Culture Lysis Reagent (Promega, #E153A) were added into each well. The plate was incubated for 15 min with rocking at room temperature. 8 μL of cell lysate from each well was added into a 384-well plate (Corning™, #3574), followed by the addition of 16 μL of Luciferase Assay Substrate (Promega, #E151A). Luciferase activity measurement was performed on a Spark 20M multimode microplate reader (Tecan). All the infection experiments were performed in a biosafety level-2 (BSL-2) laboratory.
dSTORM super-resolution imaging
Fixed cell preparation
Cells were grown to 60% confluence. Cells were incubated with 4 μg/mL purified apoE protein with or without FBS supplementation (overnight) or 100μM MβCD (30 min) in media. Cells were rinsed with PBS and then fixed with 3% paraformaldehyde and 0.1% glutaraldehyde for 20 min to fix both proteins and lipids. Fixative chemicals were reduced by incubating with 0.1% NaBH4 for 7 min with shaking followed by three times 10 min washes with PBS. Cells were permeabilized with 0.2% Triton X-100 for 15 min and then blocked with a standard blocking buffer (10% bovine serum albumin (BSA) / 0.05% Triton in PBS) for 90 min at room temperature. For labelling, cells were incubated with primary antibody (anti-ACE2 antibody (Abcam, #ab189168), anti-Furin antibody (Abcam, #ab3467) or anti-TMPRSS2 antibody [EPR3861] (Abcam, #ab92323)) for 60 min in 5% BSA / 0.05% Triton / PBS at room temperature followed by 5 washes with 1% BSA / 0.05% Triton / PBS for 15 min each. Secondary antibody (donkey anti-rabbit cy3b and CTxB-647) was added in the same buffer as primary for 30 min at room temperature followed by 5 washes as stated above. Cells were then washed with PBS for 5 min.
Cell labelling and washing steps were performed while shaking. Labeled cells were then post-fixed with fixing solution, as above, for 10 min without shaking followed by three 5 min washes with PBS and two 3 min washes with deionized distilled water.
Lung tissue preparation
Lungs were removed from C57BL/6J wild type and diet induced obesity (DIO) mice. Housing, animal care and experimental procedures were consistent with the Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee of the Scripps Research Institute. Mouse lung tissue slicing and staining were performed as previously described77 with minor modifications. Mouse tissues were fixed in 4% paraformaldehyde / 1% glutaraldehyde at 4 °C for 3 days. Tissues were sliced by the histology core. Sections (50 μm) were collected and placed into 24-well plate wells containing PBS. Fixative chemicals were reduced by incubating with 0.1% NaBH4 for 30 min while gently shaking at room temperature followed by three times 10 min washes with PBS. Samples were permeabilized with 0.2% Triton X-100 for 2 hours and then blocked with a standard blocking buffer (10% bovine serum albumin (BSA) / 0.05% Triton in PBS) for 6 hours at room temperature. For labelling, samples were incubated with primary antibody for 3 hours in 5% BSA / 0.05% Triton / PBS at room temperature then 3 days at 4 °C followed by 5 washes with 1% BSA / 0.05% Triton / PBS for 1 hour each. Secondary antibody was added in the same buffer as primary for 3 days at 4 °C followed by 5 washes as stated above. Sample labelling and washing steps were performed while shaking. Labeled lung tissues were then post-fixed with fixing solution, as above, for 1 hour without shaking followed by three 30 min washes with PBS and two 30 min washes with deionized distilled water. Lung slices were mounted onto the 35 mm glass bottom chamber (ibidi, #81158) and 2% agarose were pipetted onto the slice to form a permeable agarose pad and prevent sample movement during imaging.
dSTORM imaging
Images were recorded with a Zeiss ELYRA PS.1 microscope using TIRF mode equipped with a pilimmersion 63x objective. Andor iXon 897 EMCCD camera was used along with the Zen 10D software for image acquisition and processing. The TIRF mode in the dSTORM imaging provided low background high-resolution images of the membrane. A total of 10,000 frames with an exposure time of 18 ms were collected for each acquisition. Excitation of the Alexa Fluor 647 dye was achieved using 642 nm lasers and Cy3B was achieved using 561 nm lasers. Cells and brain tissues were imaged in a photo-switching buffer comprising of 1% β-mercaptoethanol (Sigma, #63689), and oxygen scavengers (glucose oxidase (Sigma, #G2133) and catalase (Sigma, #C40)) in 50mM Tris (Affymetrix, #22638100) + 10mM NaCl (Sigma, #S7653) + 10% glucose (Sigma, #G8270) at pH 8.0. Sample drift during acquisition was corrected by an autocorrelative algorithm.
For PIP2 imaging, images were recorded with a Bruker Vutara 352 with a 60X Olympus Silicone objective. Frames with an exposure time of 20 ms were collected for each acquisition. Excitation of the Alexa Fluor 647 dye was achieved using 640 nm lasers and Cy3B was achieved using 561 nm lasers. Laser power was set to provide isolated blinking of individual fluorophores. Cells were imaged in a photo-switching buffer comprising of 1% β-mercaptoethanol (Sigma-Aldrich, #63689), 50 mM cysteamine (Sigma-Aldrich #30070) and oxygen scavengers (glucose oxidase (Sigma, #G2133) and catalase (Sigma, #C40)) in 50mM Tris (Affymetrix, #22638100) + 10mM NaCl (Sigma, #S7653) + 10% glucose (Sigma, #G8270) at pH 8.0. Axial sample drift was corrected during acquisition through the Vutara 352’s vFocus system.
Images were constructed using the default modules in the Zen software. Each detected event was fitted to a 2D Gaussian distribution to determine the center of each point spread function plus the localization precision. The Zen software also has many rendering options including removing localization errors and outliers based on brightness and size of fluorescent signals. Pair correlation and cluster analysis was performed using the Statistical Analysis package in the Vutara SRX software. Pair Correlation analysis is a statistical method used to determine the strength of correlation between two objects by counting the number of points of probe 2 within a certain donut-radius of each point of probe 1. This allows for localization to be determined without overlapping pixels as done in traditional diffraction-limited microscopy. Raft size estimation and raft density were calculated through cluster analysis by measuring the length and density of the clusters comprising of more than 10 particles with a maximum particle distance of 0.1 μm. Ripley’s H(r) analysis was performed to study the distribution of lipid raft clusters.
Lung cholesterol assay
To measure the relative changes in cholesterol level in lung tissue, we developed an Amplex Red-based cholesterol assay. Lungs were removed from C57BL/6J wild type and diet induced obesity (DIO) mice._ Housing, animal care and experimental procedures were consistent with the Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee of the Scripps Research Institute. The left lobe of each lung was homogenized with RIPA lysis buffer. After centrifugation, supernatant was collected for cholesterol and protein measurement. 50 μL of supernatant were mixed with 50 μL of assay solution containing 100 μM Amplex red, 2 U/mL horseradish peroxidase, 4 U/mL cholesterol oxidase and 4 U/mL cholesteryl esterase in PBS in 96-well plates with transparent-bottom (Corning™ Costar™, #3585). Relative cholesterol concentration was determined for each sample by measuring fluorescence activity with a fluorescence microplate reader (Tecan Infinite 200 PRO, reading from bottom) with excitation wavelength of 530 nm and an emission wavelength of 585 nm. Subsequently, cholesterol level was normalized by tissue weights and protein concentration. Cholesterol signals were then graphed (Mean ± s.e.m.) and statistically analyzed (one-way ANOVA) with GraphPad Prism software (v6.0f).
Receptor binding domain (RBD) binding assay
HEK293T cells were seeded into 96-well flat culture plates with transparent-bottom (Corning™ Costar™, #3585) one day before experiment. SARS-CoV-2 RBD with a human Fc fusion was a generous gift from Dr. Michael Farzan (Department of Immunology and Microbiology, Scripps Research). HEK293T cells were incubated with 10 μg/mL RBD peptide in cell culture medium overnight at 37°C in 5% CO2. Cells were washed with PBS once before fixation with 3% paraformaldehyde. After blocking with a standard blocking buffer (10% bovine serum albumin (BSA) / 0.05% Triton in PBS) for 90 min at room temperature, RBD binding to the cells were labelled with Alexa 647 goat anti-human IgG (Jackson ImmunoResearch, # 109-606-098) for 6 hours at 4°C. After labelling, cells were washed with PBS twice. Relative RBD binding was determined in quintuplicate for each condition by measuring fluorescent activity with a fluorescence microplate reader (Tecan Infinite 200 PRO) with excitation wavelength of 630 nm and an emission wavelength of 680 nm.
Statistical analyses
All statistical calculations were performed in GraphPad Prism v6.0. For the Student’s t test, significance was calculated using a two-tailed unpaired parametric test with significance defined as p < 0.05, **P<0.01, ***P<0.001, ****P<0.0001.
For the multiple comparison test, significance was calculated using an ordinary one-way ANOVA with Dunnett’s multiple comparisons test.
Supplementary Material
Acknowledgements
We thank Michael Farzan for the SARS-CoV-2 spike plasmid, hACE2 overexpression HEK293T cell line, and RBD peptide; Andrew S. Hansen for helpful discussion and reading of the manuscript; Montina Van Meter from histology core and Scott Troutman from the Joseph Kissil Lab (Scripps Research, FL) for support in tissue immunohistochemistry. This work was supported by the National Institutes of Health with an R01 to S.B.H. (R01NS112534) and the US Department of Defense with an Accelerating Innovation in Military Medicine to S.B.H. (W81XWH1810782). We are grateful to the Iris and Junming Le Foundation for funds to purchase a super-resolution microscope, making this study possible.
References
- 1.Wu Z. & McGoogan J. M. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA - J. Am. Med. Assoc. 323, 13–16 (2020). [DOI] [PubMed] [Google Scholar]
- 2.Wu J. T. et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat. Med. 26, (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Chu J. et al. Clinical Characteristics of 54 medical staff with COVID-19: A retrospective study in a single center in Wuhan, China. J. Med. Virol. 0–3 (2020). doi: 10.1002/jmv.25793 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Chen T. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368, m1091 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Holly J. M. P., Biernacka K., Maskell N. & Perks C. M. Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle. Front. Endocrinol. (Lausanne). 11, 1–13 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.van Westen-Lagerweij N. A. et al. Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth. npj Prim. Care Respir. Med. 31, 2–4 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ruan Q., Yang K., Wang W., Jiang L. & Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 46, 846–848 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Stockman L. J. et al. Severe acute respiratory syndrome in children. Pediatr. Infect. Dis. J. 26, 68–74 (2007). [DOI] [PubMed] [Google Scholar]
- 9.Li W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450–4 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hoffmann M. et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181, 271–280.e8 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Matsuyama S. et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl. Acad. Sci. 117, 202002589 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Bayati A., Kumar R., Francis V. & McPherson P. S. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J. Biol. Chem. 296, 1–12 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lingwood D. & Simons K. Lipid rafts as a membrane-organizing principle. Science 327, 46–50 (2010). [DOI] [PubMed] [Google Scholar]
- 14.Li G. M., Li Y. G., Yamate M., Li S. M. & Ikuta K. Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle. Microbes Infect. 9, 96–102 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Lu Y., Liu D. X. & Tam J. P. Lipid rafts are involved in SARS-CoV entry into Vero E6 cells. Biochem. Biophys. Res. Commun. 369, 344–349 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Simmons G., Zmora P., Gierer S., Heurich A. & Pöhlmann S. Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research. Antiviral Research 100, 605–614 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Coutard B. et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Research 176, (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Hoffmann M., Kleine-Weber H. & Pöhlmann S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Mol. Cell 78, 779–784.e5 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Dang E. V., Madhani H. D. & Vance R. E. Cholesterol in quarantine. Nat. Immunol. 21, 716–717 (2020). [DOI] [PubMed] [Google Scholar]
- 20.Angel A. & Farkas J. Regulation of cholesterol storage in adipose tissue. J. Lipid Res. 15, 491–499 (1974). [PubMed] [Google Scholar]
- 21.Adams C. W., Bayliss O. B., Baker R. W., Abdulla Y. H. & Hunter-Craig C. J. Lipid deposits in ageing human arteries, tendons and fascia. Atherosclerosis 19, 429–40 (1974). [DOI] [PubMed] [Google Scholar]
- 22.Sene A. et al. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab. 17, 549–561 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Tall A. R. & Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 15, 104–116 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Gowdy K. M. & Fessler M. B. Emerging roles for cholesterol and lipoproteins in lung disease. Pulm. Pharmacol. Ther. 26, 430–7 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Fessler M. B. A new frontier in immunometabolism cholesterol in lung health and disease. Ann. Am. Thorac. Soc. 14, S399–S405 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Andersson J. M., Grey C., Larsson M., Ferreira T. M. & Sparr E. Effect of cholesterol on the molecular structure and transitions in a clinical-grade lung surfactant extract. Proc. Natl. Acad. Sci. U. S. A. 114, E3592–E3601 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Daniels L. B. et al. Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients. Am. J. Cardiol. 136, 149–155 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wang S. et al. Cholesterol 25 Hydroxylase inhibits SARS CoV 2 and coronaviruses by depleting membrane cholesterol. EMBO J. 1–13 (2020). doi: 10.15252/embj.2020106057 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Sanders D. W. et al. SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation. Elife 10, 1–47 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Schmidt N. M., Wing P. A. C., McKeating J. A. & Maini M. K. Cholesterol-modifying drugs in COVID-19. Oxford Open Immunol. 1, 1–6 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Pavel M. A., Petersen E. N., Wang H., Lerner R. A. & Hansen S. B. Studies on the mechanism of general anesthesia. Proc. Natl. Acad. Sci. U. S. A. 117, 13757–13766 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Petersen E. N., Chung H.-W., Nayebosadri A. & Hansen S. B. Kinetic disruption of lipid rafts is a mechanosensor for phospholipase D. Nat. Commun. 7, 13873 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Glende J. et al. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2. Virology 381, 215–221 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Matsuyama S. et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl. Acad. Sci. U. S. A. 117, 7001–7003 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Dicken S. J. et al. Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2. bioRxiv Prepr. Serv. Biol. (2021). doi: 10.1101/2021.03.22.436468 [DOI] [Google Scholar]
- 36.Radzikowska U. et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy Eur. J. Allergy Clin. Immunol. 75, 2829–2845 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Levental I., Lingwood D., Grzybek M., Coskun U. & Simons K. Palmitoylation regulates raft affinity for the majority of integral raft proteins. Proc. Natl. Acad. Sci. 107, 22050–22054 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Varshney P., Yadav V. & Saini N. Lipid rafts in immune signalling: current progress and future perspective. Immunology 149, 13–24 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sieben C., Sezgin E., Eggeling C. & Manley S. Influenza A viruses use multivalent sialic acid clusters for cell binding and receptor activation. PLoS Pathog. 16, e1008656 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Dou X. et al. Cholesterol of lipid rafts is a key determinant for entry and post-entry control of porcine rotavirus infection. BMC Vet. Res. 14, 1–12 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Betzig E. et al. Imaging intracellular fluorescent proteins at nanometer resolution. Science 313, 1642–1645 (2006). [DOI] [PubMed] [Google Scholar]
- 42.Hess S. T., Girirajan T. P. K. K. & Mason M. D. Ultra-high resolution imaging by fluorescence photoactivation localization microscopy. Biophys. J. 91, 4258–4272 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Sahl S. J., Hell S. W. & Jakobs S. Fluorescence nanoscopy in cell biology. Nat. Rev. Mol. Cell Biol. 18, 685–701 (2017). [DOI] [PubMed] [Google Scholar]
- 44.Quinlan B. D. et al. The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing resonse without antibody-dependent enhancement. bioRxiv 1–9 (2020). doi: 10.1101/2020.04.10.036418 [DOI] [Google Scholar]
- 45.Moore M. J. et al. Retroviruses Pseudotyped with the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Efficiently Infect Cells Expressing Angiotensin-Converting Enzyme 2. J. Virol. 78, 10628–10635 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Kuo C.-L. et al. APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort. Journals Gerontol. Ser. A 1–29 (2020). doi: 10.1093/gerona/glaa131 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Luo J., Yang H. & Song B. L. Mechanisms and regulation of cholesterol homeostasis. Nat. Rev. Mol. Cell Biol. 21, 225–245 (2020). [DOI] [PubMed] [Google Scholar]
- 48.Varma V. P. et al. Ocular fluid as a replacement for serum in cell cryopreservation media. PLoS One 10, 1–17 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Wang H., Kulas J. A., Ferris H. A. & Hansen S. B. Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol. bioRxiv 2020.06.18.159632 (2020). doi: 10.1101/2020.06.18.159632 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.van den Bogaart G. et al. Membrane protein sequestering by ionic protein-lipid interactions. Nature 479, 552–5 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Wang J. & Richards D. a. Segregation of PIP2 and PIP3 into distinct nanoscale regions within the plasma membrane. Biol. Open 1, 857–62 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Robinson C. V., Rohacs T. & Hansen S. B. Tools for Understanding Nanoscale Lipid Regulation of Ion Channels. Trends Biochem. Sci. 44, 795–806 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Petersen E. N., Pavel M. A., Wang H. & Hansen S. B. Disruption of palmitate-mediated localization; a shared pathway of force and anesthetic activation of TREK-1 channels. Biochim. Biophys. Acta - Biomembr. 1862, 183091 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Wang C.-Y. & Liao J. K. A mouse model of diet-induced obesity and insulin resistance. Methods Mol. Biol. 821, 421–33 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Petit C. M. et al. Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion. Virology 360, 264–274 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.McBride C. E. & Machamer C. E. Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell-cell fusion but not interaction with M protein. Virology 405, 139–148 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Hu X., Chen D., Wu L., He G. & Ye W. Low Serum Cholesterol Level Among Patients with COVID-19 Infection in Wenzhou, China. SSRN Electron. J. (2020). doi: 10.2139/ssrn.3544826 [DOI] [Google Scholar]
- 58.Nayebosadri A., Petersen E. N., Cabanos C. & Hansen S. B. A Membrane Thickness Sensor in TREK-1 Channels Transduces Mechanical Force. SSRN Electron. J. (2018). doi: 10.2139/ssrn.3155650 [DOI] [Google Scholar]
- 59.Petersen E. N. et al. Phospholipase D Transduces Force to TREK-1 Channels in a Biological Membrane. 758896 (2019). doi: 10.1101/758896 [DOI]
- 60.Wicht O. et al. Identification and Characterization of a Proteolytically Primed Form of the Murine Coronavirus Spike Proteins after Fusion with the Target Cell. J. Virol. (2014). doi: 10.1128/jvi.03451-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Chen J., Zhang X., Kusumo H., Costa L. G. & Guizzetti M. Cholesterol efflux is differentially regulated in neurons and astrocytes: Implications for brain cholesterol homeostasis. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 1831, 263–275 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Hayashi H., Campenot R. B., Vance D. E. & Vance J. E. Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1. J. Neurosci. 27, 1933–1941 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Lindh M. et al. Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer’s disease patients are increased at follow up and show a correlation with levels of tau protein. Neurosci. Lett. (1997). doi: 10.1016/S0304-3940(97)00429-1 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.